1034188-31-2 Usage
Molecular structure
2-(trifluoromethyl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-4-carboxylic acid is derived from a biphenyl molecule and contains a carboxylic acid functional group, with a trifluoromethyl group attached to the 2-position of the biphenyl core.
Chemical classification
It is an organofluorine compound due to the presence of the trifluoromethyl group, and it is also a tetrahydrobiphenylcarboxylic acid.
Potential applications
2-(trifluoromethyl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-4-carboxylic acid can have specific applications in the pharmaceutical and agrochemical industries, as the presence of the trifluoromethyl group can influence its interactions with biological systems and potential therapeutic properties.
Drug development
The compound's structure and properties make it potentially useful for the development of new drugs, as it may have unique interactions with biological targets and offer novel therapeutic effects.
Synthesis building block
2-(trifluoromethyl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-4-carboxylic acid can be used as a building block for the synthesis of various organic compounds, due to its unique structure and reactivity, allowing for the creation of a diverse range of molecules with different properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1034188-31-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,4,1,8 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1034188-31:
(9*1)+(8*0)+(7*3)+(6*4)+(5*1)+(4*8)+(3*8)+(2*3)+(1*1)=122
122 % 10 = 2
So 1034188-31-2 is a valid CAS Registry Number.
1034188-31-2Relevant academic research and scientific papers
PROCESS FOR PREPARATION OF SIPONIMOD, ITS SALTS AND SOLID STATE FORMS THEREOF
-
Page/Page column 30; 31, (2019/04/26)
The present application provides process for preparation of siponimod, intermediates of siponimod, salts of siponimod, polymorphic forms and solid dispersions of siponimod and its salts thereof. The present application specifically provides crystalline polymorphic forms of siponimod base, siponimod hemifumarate and other salts and pharmaceutical compositions thereof. Also provided are solid dispersions of siponimod hemifumarate and pharmaceutical compositions containing them.
AZETIDINE MODULATORS OF THE SPHINGOSINE 1-PHOSPHATE RECEPTOR
-
Paragraph 00247-00248, (2017/08/01)
Described are deuterium-substituted azetidine compounds of Formula (I), which are modulators of sphingosine 1 -phosphate receptor. Also described are pharmaceutical compositions comprising the deuterium-substituted azetidine compounds, and methods of use thereof.
PROCESS FOR PREPARING N-(4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXY)-ACETIMIDIC ACID ETHYL ESTER
-
Page/Page column 32-33, (2013/08/15)
This invention relates to novel processes for synthesizing N-(4-cyclohexyl-3-trifluoromethyl-benzyloxy)-acetimidic acid ethyl ester and to the compound of formula I and other intermediates that are used in such processes.
OXADIAZOLE DERIVATIVES AS S1P1 RECEPTOR AGONISTS
-
Page/Page column 30, (2008/12/06)
The present invention relates to novel oxadiazole compounds of formula (I) having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
